|
Orenes-Piñero E, Hernández-Romero D, Jover E, Valdés M, Lip GY, Marín F. Impact of polymorphisms in the renin-angiotensin-aldosterone system on hypertrophic cardiomyopathy. J Renin Angiotensin Aldosterone Syst. 2011 Dec;12(4):521-30. doi: 10.1177/1470320311405247. Epub 2011 Apr 20. Review. PubMed PMID: 21507890.
AÑO: 2011; IF: 2.439
|
21507890
|
Orenes-Piñero E, Hernández-Romero D, Jover E, de la Morena G, Valdés M, Marín F. An insight of novel pharmacological therapies in hypertrophic cardiomyopathy. Med Chem. 2011 Jul;7(4):275-85. Review. PubMed PMID: 21568880.
AÑO: 2011; IF: 1.496
|
|
Muñoz-Esparza C, Jover E, Hernández-Romero D, Saura D, Valdés M, Lip GY, Marín F. Interactions between clopidogrel and proton pump inhibitors: a review of evidence. Curr Med Chem. 2011;18(16):2386-400. Review. PubMed PMID: 21568918.
AÑO: 2011; IF: 4.859
|
|
Marín F, Roldán V, Martínez JG, Hernández-Madrid A, Hernández-Romero D, Ortego M, Ibáñez A, Marín-Marín I, Navarro X, Lip GY, Moro C. Influence of cardiac resynchronization therapy on indices of inflammation, the prothrombotic state and tissue remodeling in systolic heart failure: a pilot study. Thromb Res. 2011 Oct;128(4):391-4. doi: 10.1016/j.thromres.2011.05.022. Epub 2011 Jun 26. PubMed PMID: 21708399.
AÑO: 2011; IF: 2.44
|
|
Hernández-Romero D, Jover E, Marín F, Vilchez JA, Manzano-Fernandez S, Romera M, Vicente V, Valdés M, Lip GY, Roldán V. The prognostic role of the adiponectin levels in atrial fibrillation. Eur J Clin Invest. 2013 Feb;43(2):168-73. doi: 10.1111/eci.12028. Erratum in: Eur J Clin Invest. 2013 Apr;43(4):428. PubMed PMID: 23278336.
AÑO: 2013; IF: 2.834
|